Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients

The Role of the Bone Marrow Microenvironment in the Pathogenesis of Acute Myeloid Leukemia.

Biomedicines·2026

Outcomes, Treatment Patterns, and Resource Use in European Adults with Immune Thrombocytopenia Treated with Avatrombopag.

TH open : companion journal to thrombosis and haemostasis·2026

Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

British journal of haematology·2026

Effect of efgartigimod IV on immature platelet fraction in primary immune thrombocytopenia in the ADVANCE IV trial.

British journal of haematology·2026

Real-World Treatment Patterns and Physician Perspectives in Relapsed/Refractory Multiple Myeloma: Results From a Nationwide Italian GIMEMA Survey.

EJHaem·2026

Clinical and Biological Implications of TP53 Abnormalities in Relapsed/Refractory Multiple Myeloma: The DEDALO Study.

Clinical lymphoma, myeloma & leukemia·2026

Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study.

Haematologica·2026

Surveying survival: benchmarking acute myeloid leukemia outcomes without transplant.

Haematologica·2026

Measurable residual KMT2A partial tandem duplication before allogeneic stem cell transplantation in acute myeloid leukemia.

Haematologica·2026

Normal platelet function in a patient with ARHGEF1 deficiency.

Haematologica·2026

Bone marrow biopsy characteristics at nadir after intensive induction therapy do not predict outcomes in adult acute myeloid leukemia patients: an analysis of ECOG-ACRIN clinical trials.

Haematologica·2026

Efficacy and safety of bridging therapy prior to CAR T-cell therapy in relapsed or refractory multiple myeloma.

Haematologica·2026

Emerging biodegradable nanomaterials for innovative tumor immunotherapy.

Journal of materials chemistry. B·2026

The First Pan-African Survey of Interventional Pulmonology: Current Practice, Training Gaps, and Barriers.

Journal of bronchology & interventional pulmonology·2026

Switching Between Anti-TNFs and Other Biologic Drugs in Paediatric Inflammatory Bowel Disease: A Narrative Review and Practical Clinical Guide.

Journal of inflammation research·2026

Tissue and blood-based predictive biomarkers in hepatocellular carcinoma immunotherapy: synthesis of 2023-2026 evidence and a proposed clinical integration framework.

Frontiers in oncology·2026

Adjuvant treatment of gastrointestinal stromal tumors (GIST)-state of the art, controversies, and future directions.

ESMO gastrointestinal oncology·2026

Related Experiment Videos

Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients

Related Concept Videos

The Role of the Bone Marrow Microenvironment in the Pathogenesis of Acute Myeloid Leukemia.

Outcomes, Treatment Patterns, and Resource Use in European Adults with Immune Thrombocytopenia Treated with Avatrombopag.

Salvage treatment patterns in multiple myeloma patients progressing after lenalidomide maintenance: A real-life study from European Myeloma Network (EMN) Italy.

Effect of efgartigimod IV on immature platelet fraction in primary immune thrombocytopenia in the ADVANCE IV trial.

Real-World Treatment Patterns and Physician Perspectives in Relapsed/Refractory Multiple Myeloma: Results From a Nationwide Italian GIMEMA Survey.

Clinical and Biological Implications of TP53 Abnormalities in Relapsed/Refractory Multiple Myeloma: The DEDALO Study.

Cusatuzumab combined with venetoclax with or without azacitidine in unfit patients with newly diagnosed acute myeloid leukemia: phase Ib ELEVATE study.

Surveying survival: benchmarking acute myeloid leukemia outcomes without transplant.

Measurable residual KMT2A partial tandem duplication before allogeneic stem cell transplantation in acute myeloid leukemia.

Normal platelet function in a patient with ARHGEF1 deficiency.

Bone marrow biopsy characteristics at nadir after intensive induction therapy do not predict outcomes in adult acute myeloid leukemia patients: an analysis of ECOG-ACRIN clinical trials.

Efficacy and safety of bridging therapy prior to CAR T-cell therapy in relapsed or refractory multiple myeloma.

Emerging biodegradable nanomaterials for innovative tumor immunotherapy.

The First Pan-African Survey of Interventional Pulmonology: Current Practice, Training Gaps, and Barriers.

Switching Between Anti-TNFs and Other Biologic Drugs in Paediatric Inflammatory Bowel Disease: A Narrative Review and Practical Clinical Guide.

Tissue and blood-based predictive biomarkers in hepatocellular carcinoma immunotherapy: synthesis of 2023-2026 evidence and a proposed clinical integration framework.

Adjuvant treatment of gastrointestinal stromal tumors (GIST)-state of the art, controversies, and future directions.

Related Experiment Videos

Thalidomide before autologous stem cell transplantation in VAD-refractory multiple myeloma patients

Related Concept Videos

Related Articles